StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Non-GAAP diluted earnings per share by Year

Non-GAAP diluted earnings per share ($) ($)

Eli Lilly Non-GAAP diluted earnings per share: $24.21 in FY2025, up 86.4% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
24.21
Period ended Dec 31, 2025
Change on a year earlier
+86.4%
12.99 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Earnings per share (diluted) - Non-GAAP | $ | 7.54 | $ | 5.32 | $ | 24.21 | $ | 12.99 1.Excludes amortization of intangibles primarily associated with costs of marketed products acquired or licensed from third parties.”

Source: Earnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗

Reported in Form 8-K Non-GAAP Reconciliation Schedules.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Eli Lilly Non-GAAP diluted earnings per share ($), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/eps-nongaap

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.